Brookstone Capital Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-1,854
Closed -$360K 746
2021
Q1
$360K Sell
1,854
-1,736
-48% -$356K 0.01% 378
2020
Q4
$688K Buy
+3,590
New +$653K 0.03% 292

Other funds holding RGEN

Brookstone Capital Management's RGEN Position: Q2 2021 in Review

Brookstone Capital Management sold out of Repligen (RGEN) in Q2 2021, closing a stake of 1,854 shares — an estimated $360K sold.

Brookstone Capital Management first reported a position in RGEN in Q4 2020 and held it in 2 quarters. The position peaked at $688K in Q4 2020. 428 funds tracked by Wall St. Rank hold RGEN as of Q2 2021.

  • Brookstone Capital Management reported no remaining Repligen position as of Q2 2021 after selling out during the quarter.
  • Brookstone Capital Management sold 1,854 Repligen shares in Q2 2021, an estimated $360K.
  • Brookstone Capital Management first reported a position in Repligen in Q4 2020 and held it in 2 quarters.
  • Brookstone Capital Management's Repligen position peaked at $688K in Q4 2020.
  • 428 funds tracked by Wall St. Rank held Repligen as of Q2 2021.

Based on Brookstone Capital Management's 13F filing for Q2 2021, filed 14 Jul 2021.